Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities
Net income (loss)	$ (53,906)	$ (104,800)	$ 8,472
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	24,599	24,628	25,931
Share-based compensation expense	1,085	1,122	1,594
Loss on disposal of property and equipment	3,060	54	470
Change in fair value of business combination liability	(6,000)
Gain on extinguishment of convertible notes	(84)
Equity in net loss of joint ventures	3,148	169	34
Deferred income taxes	(129)	82,394	(628)
Effect of foreign currency translation	(66)
Changes in operating assets and liabilities, net of acquisitions
Accounts receivable	4,232	1,249	27,816
Inventory	12,906	(10,666)	(3,020)
Prepaid expenses and other	(6,367)	11,793	2,936
Income tax receivable		158	(5,114)
Accounts payable	(12,518)	12,173	(16,700)
Accrued expenses	16,283	4,994	(8,330)
Income taxes (payable) receivable	5,750	10,193	(4,269)
Reserve for sales returns and allowances	(2,999)	(9,067)	15,062
Other liabilities	(11,324)	(97)	5
Excess tax deficiency from exercise of stock options and vesting of restricted stock	(160)	(114)
Total adjustments	31,416	128,983	35,787
Net cash provided by (used in) operating activities	(22,490)	24,183	44,259
Cash flows from investing activities
Purchases of property and equipment	(10,129)	(13,066)	(12,455)
Change in other assets	(135)	(459)	271
Proceeds from sale of property and equipment			26
Investment in DreamPlay LLC		(7,000)
Contributions to joint venture	(1,636)	(1,524)	(2,696)
Distributions from joint venture	1,149	930
Cash paid for intangible assets		(8,000)
Cash paid for net assets of businesses acquired		(43,620)	(21,429)
Net purchases of marketable securities	(2)	(5)	(7)
Net cash used in investing activities	(10,753)	(72,744)	(36,290)
Cash flows from financing activities
Proceeds from stock options exercised		101	276
Proceeds from warrants exercised			1,135
Common stock surrendered	(34)	(103)	(1,263)
Common stock repurchased		(80,000)	(24,359)
Proceeds from (repayment of) credit facility borrowings	(70,710)	70,710
Credit facility costs		(546)
Dividends paid	(3,084)	(9,538)	(5,182)
Proceeds from issuance of convertible notes	100,000
Bank fees related to convertible notes	(4,179)
Retirement of senior convertible notes	(61,000)		(27)
Tax benefit from stock options exercised			363
Net cash used in financing activities	(39,007)	(19,376)	(29,057)
Net decrease in cash and cash equivalents	(72,250)	(67,937)	(21,088)
Cash and cash equivalents, beginning of year	189,321	257,258	278,346
Cash and cash equivalents, end of year	117,071	189,321	257,258
Cash paid (refunded) during the period for:
Interest	4,408	5,051	4,534
Income taxes	$ (4,644)	$ (9,020)	$ (7,249)